Developing an Ex Vivo Model of the Mesolimbic Pathway for Studying Drug Responses.
dc.contributor.advisor | Albert Keung, Chair | |
dc.contributor.advisor | Balaji Rao, Member | |
dc.contributor.advisor | Jason Haugh, Member | |
dc.contributor.advisor | Elizabeth Lucas, Member | |
dc.contributor.author | Rudibaugh, Thomas Paul | |
dc.date.accepted | 2023-07-24 | |
dc.date.accessioned | 2023-07-27T12:30:25Z | |
dc.date.available | 2023-07-27T12:30:25Z | |
dc.date.defense | 2023-06-21 | |
dc.date.issued | 2023-06-21 | |
dc.date.released | 2023-07-27 | |
dc.date.reviewed | 2023-07-21 | |
dc.date.submitted | 2023-07-18 | |
dc.degree.discipline | Chemical Engineering | |
dc.degree.level | dissertation | |
dc.degree.name | Doctor of Philosophy | |
dc.identifier.other | deg34738 | |
dc.identifier.uri | https://www.lib.ncsu.edu/resolver/1840.20/41216 | |
dc.title | Developing an Ex Vivo Model of the Mesolimbic Pathway for Studying Drug Responses. |
Files
Original bundle
1 - 1 of 1